https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7785422/
“Patients with hypertension are commonly treated with the renin angiotensin system (RAS) antagonists, such as angiotensin converting enzyme inhibitors (ACE1s) or angiotensin receptor blockers (ARBs) in the control of blood pressure.
“However, these drugs have been reported to increase the expression of angiotensin converting enzyme 2 (ACE2), which is recognized as the receptor of SARS-CoV-2 in the cell surface, especially the lung epithelial cells.
“Thus, there has been a speculation that this class of antihypertension drugs might facilitate the infection and replication of the virus.
“On the other hand, some researchers believed that the expression may be a beneficial response in terms of limiting the lung injuries by the infection. Collectively, the exact impact of ACE1s and ARBs in the infection is still under debate. Here we present two lines of justifications supporting the hypothesis that those hypertension medicines may reduce the mortality in COVID-19 patients.”
Thanks, Pelham.
“Here we present two lines of justifications supporting the hypothesis that those hypertension medicines may reduce the mortality in COVID-19 patients.””
They’ll protect their drug pipeline at any cost. In this case, you’d think, if they were being honest, they would have told us that people with high blood pressure, who are on meds for it, are more PROTECTED against the virus, rather than telling us the opposite.